Lead sponsor
St. Joseph's Hospital and Medical Center, Phoenix
4 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
4
Trials led
2
Ongoing
199
Total enrollment
4
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
3
Phase 4
1
Trials by status
Not yet recruiting
1
Recruiting
1
Completed
1
Terminated
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
MCLENA-2: A Phase II Clinical Trial for the Assessment of Lenalidomide in Patients With Mild Cognitive ImpairmentAmyloid biomarker required (PET)Ph 2Not yet recruiting45
Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's DiseaseAlzheimer's diseasePh 4Terminated34